918 related articles for article (PubMed ID: 29917054)
1. Somatic copy number gains of α-synuclein (SNCA) in Parkinson's disease and multiple system atrophy brains.
Mokretar K; Pease D; Taanman JW; Soenmez A; Ejaz A; Lashley T; Ling H; Gentleman S; Houlden H; Holton JL; Schapira AHV; Nacheva E; Proukakis C
Brain; 2018 Aug; 141(8):2419-2431. PubMed ID: 29917054
[TBL] [Abstract][Full Text] [Related]
2. Investigation of somatic CNVs in brains of synucleinopathy cases using targeted SNCA analysis and single cell sequencing.
Perez-Rodriguez D; Kalyva M; Leija-Salazar M; Lashley T; Tarabichi M; Chelban V; Gentleman S; Schottlaender L; Franklin H; Vasmatzis G; Houlden H; Schapira AHV; Warner TT; Holton JL; Jaunmuktane Z; Proukakis C
Acta Neuropathol Commun; 2019 Dec; 7(1):219. PubMed ID: 31870437
[TBL] [Abstract][Full Text] [Related]
3. Somatic SNCA Copy Number Variants in Multiple System Atrophy are Related to Pathology and Inclusions.
Garcia-Segura ME; Perez-Rodriguez D; Chambers D; Jaunmuktane Z; Proukakis C
Mov Disord; 2023 Feb; 38(2):338-342. PubMed ID: 36448620
[TBL] [Abstract][Full Text] [Related]
4. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
5. Somatic mutations in neurodegeneration: An update.
Proukakis C
Neurobiol Dis; 2020 Oct; 144():105021. PubMed ID: 32712267
[TBL] [Abstract][Full Text] [Related]
6. Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders.
Tong J; Rathitharan G; Meyer JH; Furukawa Y; Ang LC; Boileau I; Guttman M; Hornykiewicz O; Kish SJ
Brain; 2017 Sep; 140(9):2460-2474. PubMed ID: 29050386
[TBL] [Abstract][Full Text] [Related]
7. Genetics of Synucleinopathies.
Nussbaum RL
Cold Spring Harb Perspect Med; 2018 Jun; 8(6):. PubMed ID: 28213435
[TBL] [Abstract][Full Text] [Related]
8. Alpha-synuclein dynamics in induced pluripotent stem cell-derived dopaminergic neurons from a Parkinson's disease patient (PARK4) with SNCA triplication.
Fukusumi H; Togo K; Sumida M; Nakamori M; Obika S; Baba K; Shofuda T; Ito D; Okano H; Mochizuki H; Kanemura Y
FEBS Open Bio; 2021 Feb; 11(2):354-366. PubMed ID: 33301617
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylated α-synuclein in skin nerve fibres differentiates Parkinson's disease from multiple system atrophy.
Zange L; Noack C; Hahn K; Stenzel W; Lipp A
Brain; 2015 Aug; 138(Pt 8):2310-21. PubMed ID: 26017579
[TBL] [Abstract][Full Text] [Related]
10. Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients.
Chiba-Falek O; Lopez GJ; Nussbaum RL
Mov Disord; 2006 Oct; 21(10):1703-8. PubMed ID: 16795004
[TBL] [Abstract][Full Text] [Related]
11. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease.
Galiano-Landeira J; Torra A; Vila M; Bové J
Brain; 2020 Dec; 143(12):3717-3733. PubMed ID: 33118032
[TBL] [Abstract][Full Text] [Related]
12. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
[TBL] [Abstract][Full Text] [Related]
13. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation.
Fishbein I; Kuo YM; Giasson BI; Nussbaum RL
Brain; 2014 Dec; 137(Pt 12):3235-47. PubMed ID: 25351739
[TBL] [Abstract][Full Text] [Related]
15. Novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology.
Pasanen P; Myllykangas L; Siitonen M; Raunio A; Kaakkola S; Lyytinen J; Tienari PJ; Pöyhönen M; Paetau A
Neurobiol Aging; 2014 Sep; 35(9):2180.e1-5. PubMed ID: 24746362
[TBL] [Abstract][Full Text] [Related]
16. Genes Implicated in Familial Parkinson's Disease Provide a Dual Picture of Nigral Dopaminergic Neurodegeneration with Mitochondria Taking Center Stage.
Franco R; Rivas-Santisteban R; Navarro G; Pinna A; Reyes-Resina I
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924963
[TBL] [Abstract][Full Text] [Related]
17. Genetic Variants of SNCA Are Associated with Susceptibility to Parkinson's Disease but Not Amyotrophic Lateral Sclerosis or Multiple System Atrophy in a Chinese Population.
Chen Y; Wei QQ; Ou R; Cao B; Chen X; Zhao B; Guo X; Yang Y; Chen K; Wu Y; Song W; Shang HF
PLoS One; 2015; 10(7):e0133776. PubMed ID: 26208350
[TBL] [Abstract][Full Text] [Related]
18. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of SNCA gene expression: implications to synucleinopathies.
Tagliafierro L; Chiba-Falek O
Neurogenetics; 2016 Jul; 17(3):145-57. PubMed ID: 26948950
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance and exendin-4 treatment for multiple system atrophy.
Bassil F; Canron MH; Vital A; Bezard E; Li Y; Greig NH; Gulyani S; Kapogiannis D; Fernagut PO; Meissner WG
Brain; 2017 May; 140(5):1420-1436. PubMed ID: 28334990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
